SEC Form 4 · accession 0001209191-18-050350
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sabrina Martucci Johnson
Officer — Chief Executive Officer · Director
Period of report
Sep 7, 2018
Accepted (ET)
Sep 10, 2018 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.01 | Sep 7, 2018 | A | 192,000 | A | — | Sep 7, 2028 | Common Stock | 192,000 | 192,000 | D |
Explanation of responses
- F1This stock options vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.